Medical Nonwoven Market Report 2026

The medical nonwoven market size has grown strongly in recent years. It will grow from $11.49 billion in 2025 to $12.31 billion in 2026 at a compound annual growth rate (CAGR) of 7.1%. The growth in the historic period can be attributed to rise in hospital-acquired infections awareness, growth of disposable healthcare products, expansion of global healthcare infrastructure, increasing surgical procedures worldwide, demand for cost-effective hygiene solutions.

The medical nonwoven market size is expected to see strong growth in the next few years. It will grow to $16.32 billion by 2030 at a compound annual growth rate (CAGR) of 7.3%. The growth in the forecast period can be attributed to aging global population, rising chronic disease prevalence, advancement in biodegradable nonwoven materials, expansion of home healthcare services, stricter infection control regulations. Major trends in the forecast period include rising demand for disposable infection-control medical textiles, expansion of surgical-grade barrier protection materials in hospitals, growth of cost-effective single-use hygiene products in healthcare, increasing adoption of high-filtration nonwoven materials in wound care, surge in demand for lightweight breathable medical fabrics in home healthcare.

The increasing number of surgical procedures is expected to propel the growth of the medical nonwoven market going forward. Surgical procedures refer to medical interventions performed in operating rooms that involve incisions, tissue manipulation, or suturing, typically conducted under anesthesia. The rising volume of surgical procedures is contributing to this growth due to the increasing prevalence of chronic diseases such as cardiovascular disorders, cancer, and diabetes, as these conditions often necessitate operative interventions for effective management. The higher frequency of surgeries is further supporting increased consumption of medical nonwovens, as these materials are essential components of sterile drapes, surgical gowns, face masks, and wound care products used throughout every operative procedure. For instance, in June 2024, according to the American Society of Plastic Surgeons, a US-based professional medical organization, in 2023, liposuction continued to be the most sought-after plastic surgery procedure, with nearly 350,000 procedures performed, marking a 7% increase compared to 2022. Therefore, the increasing number of surgical procedures is propelling the growth of the medical nonwoven market.

The growing prevalence of chronic diseases is expected to propel the growth of the medical nonwoven market going forward. Chronic diseases are long-term health conditions such as diabetes, heart disease, and cancer that require continuous medical management and care. The rising prevalence of chronic diseases is largely contributing to market expansion, driven by aging populations, as older individuals are significantly more susceptible to developing multiple chronic conditions simultaneously, thereby placing sustained and increasing pressure on healthcare systems. The growing burden of chronic diseases is further supporting and amplifying the demand for sterile, single-use protective medical products used in wound care, surgical procedures, and patient management, thereby directly fueling the consumption of medical nonwoven materials. For instance, in January 2026, according to the Centers for Disease Control and Prevention (CDC), a US-based government public health agency, the estimated number of people with diagnosed or undiagnosed diabetes in the United States increased from 37.3 million in 2022 to over 40.1 million in 2023, reflecting a notable rise in chronic disease burden across the country. Therefore, the growing prevalence of chronic diseases is propelling the growth of the medical nonwoven market.

Leading companies operating in the medical nonwoven market are focusing on developing advanced solutions such as binder-free bio-based nonwovens to improve sustainability, enhance material performance, and reduce environmental impact in healthcare applications. Binder-free bio-based nonwovens refer to innovative fabric materials that eliminate the need for chemical binders, offering improved biodegradability, softness, and strength while maintaining high hygiene standards. For example, in November 2025, Freudenberg Performance Materials, a Germany-based nonwoven manufacturer, launched wetlaid nonwovens combining wood pulp and polylactic acid (PLA). This innovative material combines renewable PLA fibers with wood pulp to deliver enhanced absorbency, strength, and environmental sustainability. Designed to support applications in hygiene and potential medical use, the product aligns with growing demand for eco-friendly disposable materials in healthcare and contributes to reducing reliance on synthetic, non-biodegradable nonwoven solutions.

Major companies operating in the medical nonwoven market are Kimberly-Clark Corporation, Asahi Kasei Corporation, Toray Industries Inc., DuPont de Nemours Inc., Unicharm Corporation, Johns Manville Corporation, Ahlstrom Holding 3 Oy, Freudenberg Performance Materials GmbH & Co. KG, Sateri Jiangxi Chemical Fibre Co. Ltd., Suominen Corporation, China Lucky Film Corporation, PFNonwovens a. s., Fibertex Nonwovens A/S, Zhejiang Xinlong Nonwoven Material Co. Ltd., Redifil Nonwovens Private Limited, Monadnock Non-Woven LLC, Mogul Nonwovens Sanayi ve Ticaret A. Ş., Applied Nonwoven Industries Inc., SAAF Nonwoven Pty Ltd, Dalian Ruiguang Nonwoven Group Co. Ltd.

North America was the largest region in the medical nonwoven market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the medical nonwoven market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in the medical nonwoven market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The medical nonwoven consists of sales of surgical masks, isolation gowns, surgical drapes, and wound dressings. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.